Development of radiolabeled peptides to target p185HER2/neu receptors of cancer

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 49, Issue 14, 2006, Pages 1259-1271

  Su, Zifen ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

AHNP; EP6; p185HER2 neu proteins; Peptides; Technetium 99m

Indexed keywords

BINDING ENERGY; CANCER CELLS; DIAGNOSIS; DISEASES; INDIUM COMPOUNDS;

99M-TC-DTPA; AHNP; BIACORE; CANCER CELLS; CANCER DIAGNOSIS; EP6; LABELINGS; P185HER2/NEU PROTEIN; PEPTIDOMICS; TECHNETIUM-99M;

PEPTIDES;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PENTETIC ACID; PEPTIDE; PROTEIN P185; TECHNETIUM 99M;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN;

ANIMALIA;

EID: 33947188277     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1137     Document Type: Article

References (29)

1. Shigematsu H, Takahashi H, Nomura M, Majmudar K, Suzuki M, Lee H, Wistuba II, Fong KM, Toyooka S, Shimizu N, Fujisawa T, Minna JD, Gazdar AF. Cancer Res 2005; 65: 1642-1646.
2. Hulit J, Lee RJ, Russell RG, Pestell RG. Biochem Pharmacol 2002; 64: 827-836.
3. Skirnisdottir I, Sorbe B, Seidal T. Int J Gynecol Cancer 2001; 11: 119-129.
4. Suo Z, Risberg B, Karlsson MG, Villman K, Skovlund E, Nesland JM. Int J Surg Pathol 2002; 10: 91-99.
5. Mellinghoff IK, Tran C, Sawyers CL. Cancer Res 2002; 62: 5254-5259.
6. Smith V, Hobbs S, Court W, Eccles S, Workman P, Kelland LR. Anticancer Res 2002; 22: 1993-1999.
7. Korc M. Surg Oncol Clin N Am 1998; 7: 25-41.
8. Brandt BH, Roetger A, Dittma T, Nikolai G, Seeling M, Merschjann A, Nofer JR, Dehmer-Moller G, Junker R, Assmann G, Zaenker KS. FASEB J 1999; 13: 1939-1949.
9. Herbst RS, Shin DM. Cancer 2002; 94: 1593-1611.
10. Nunes RA, Harris LN. Clin Breast Cancer 2002; 3: 125-135.
11. Morris C. Breast Cancer Res Treat 2002; 75: 51-55.
12. Saukville EA, El-Sayed Y, Monga M, Kim G. Annu Rev Clin Breast Cancer 2002; 3: 125-135; discussion 136-137
13. Pharmacol Toxicol 2003; 43: 199-231.
14. Wester K, Sjostrom A, de la Torre M, Carlsson J, Malmstrom PU. Acta Oncol 2002; 41: 282-288.
15. Liu B, Fan Z. Oncogene 2001; 20: 3726-3734.
16. Herbst RS, Hong WK. Semin Oncol 2002; 5: 18-30.
17. Reilly RM, Kiarash R, Sandhu J, Lee YW, Cameron RG, Hendler A, Vallis K, Gariepy J. J Nucl Med 2000; 41: 903-911.
18. Emens LA. Am J Ther 2005; 12: 243-253.
19. Spiridon CI, Ghetie MA, Uhr J, Marches R, Li JL, Shen GL, Vitetta ES. Clin Cancer Res 2002; 8: 1720-1730.
20. Borrero CG, McCook B, Mountz JM. Clin Nucl Med 2005; 30: 218-221.
21. Schmitt A, Bernhardt P, Nilsson O, Ahlman H, Kolby L, Forssell-Aronsson E. Cancer Biother Radiopharm 2005; 20: 231-236.
22. Buchegger F, Bonvin F, Kosinski M, Schaffland AO, Prior J, Reubi JC, Blauenstein P, Tourwe D, Garcia Garayoa E, Bischof Delaloye A. J Nucl Med 2003; 44: 1649-1654.
23. Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Brenneman K, Pili R, Pomper M, Carducci MA, Wagner Jr HN. Bioconjug Chem 2005; 16: 43-50.
24. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS. J Nucl Med 2004; 45: 1776-1783.
25. Berezov A, Zhang HT, Greene MI, Murali R. J Med Chem 2001; 44: 2565-2574.
26. Park BW, Zhang HT, Wu C, Berezov A, Zhang X, Dua R, Wang Q, Kao G, O'Rourke DM, Greene MI, Murali R. Nat Biotechnol 2001; 18: 194-198.
27. Hnatowich DJ, Layne WW, Childs RL, Lanteigne D, Davis MA, Griffin TW, Doherty PW. Science 1983; 220: 613-615.
28. Bhujwalla ZM, Artemov D, Aboagye E, Ackerstaff E, Gillies RJ, Natarajan K, Solaiyappan M. Novartis Found Symp 2001; 240: 23-38; discussion 38-45, 152-153.
29. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. Int J Radiat Oncol Biol Phys 2001; 51: 349-353.